NCT03958292 is a NA clinical trial of IODIM in Endophthalmitis Following Cataract Surgery, sponsored by Ospedale Sacra Famiglia - Fatebenefratelli Erba.

Who is sponsoring NCT03958292?

NCT03958292 is sponsored by Ospedale Sacra Famiglia - Fatebenefratelli Erba.

What drugs are being tested in NCT03958292?

Interventions in NCT03958292: IODIM.

What condition does NCT03958292 study?

NCT03958292 studies Endophthalmitis Following Cataract Surgery.

Is NCT03958292 still recruiting?

NCT03958292 is currently completed. Last updated 22 May 2019.

Last reviewed 2019-05-22 · How we verify

NCT03958292

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Conjunctival Flora Before Cataract Surgery: a Microbiological Evaluation

Completed NA Last updated 22 May 2019

What this trial tests

NA trial testing IODIM in Endophthalmitis Following Cataract Surgery in 140 participants. Completed in 30 March 2019.

Timeline

8 January 2018

Primary endpoint
29 October 2018

30 March 2019

Quick facts

Lead sponsor	Ospedale Sacra Famiglia - Fatebenefratelli Erba
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	140
Start date	8 January 2018
Primary completion	29 October 2018
Estimated completion	30 March 2019
Sites	6 locations across Italy

Drugs / interventions tested

IODIM

Conditions studied

Endophthalmitis Following Cataract Surgery — all drugs for Endophthalmitis Following Cataract Surgery →

Sponsor

Ospedale Sacra Famiglia - Fatebenefratelli Erba

Who can join

Adults 40 to 80, any sex, with Endophthalmitis Following Cataract Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the present study is to elucidate the qualitative and quantitative variation of ocular flora after treatment with eyedrops containing 0.6% povidone-iodine in the eye of patients undergoing routine cataract surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of 0.66% Povidone-Iodine Eye Drops on Ocular Surface Flora before Cataract Surgery: A Nationwide Microbiological Study.
Musumeci R, Troiano P, Martinelli M, Piovella M, et al · · 2021 · cited 13× · PMID 34069600 · DOI 10.3390/jcm10102198

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03958292 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ospedale Sacra Famiglia - Fatebenefratelli Erba
Last refreshed: 22 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03958292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing